Major Depressive DisorderTRIAGE-PsychNCT05800925
Triage Survey for Psychiatry Research Eligibility
An observational study of Major Depressive Disorder and Borderline Personality Disorder, run by Adams Clinical at 6 sites in United States.
Trial summary
TRIAGE-Psych is a survey study designed to assess potential participants' eligibility to screen for industry-sponsored psychiatry clinical trials. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Major Depressive Disorder, Borderline Personality Disorder, Generalized Anxiety Disorder
- What is being tested?
- Survey
- How many people
- 20,000 participants
- Where
- 6 sitesUnited States
- Study dates
- 21 Dec 2021to 31 Dec 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Participants of any sex, age 18+, who have expressed interest in participating in an industry-sponsored clinical trial of an investigational product for indications in psychiatry will be screened for clinical appropriateness for a study trial.
Who may be able to join
- Participant or Legally Authorized Representative has signed an ICF prior to study-specific procedures being performed.
- Participant is at least 18 years old.
Who cannot join
- Participant is pregnant, breast-feeding, or planning to become pregnant.
- History of a clinically significant illness which in the investigator's opinion may impact participant safety or the ability to analyze study results.
- Participant represents an acute suicidal risk, as defined as a "yes" response to ideation on C-SSRS questions 4 or 5, or answer "yes" to behavior questions within 90 days of screening.
- Moderate or severe substance use disorder within 90 days prior to screen, according to DSM-5 criteria that in the investigator's opinion could pose undue risk to the participant.
- Any condition that in the investigator's opinion makes a participant unsuitable for the study.
- Currently employed by Adams Clinical or a first-degree relative of an employee.
Trial locations and contacts
6 sites in 1 country. Contact the study team or a site near you to ask about taking part.
6 sites in 1 country
United States6 sites, 6 recruiting
- Recruiting
Adams Clinical, Boston
Boston, Massachusetts, 02116
Karla Meehan, MA, 617-209-3469, kmeehan@adamsclinical.com
Dyanna Domilici, MD
- Recruiting
Adams Clinical, Dallas
DeSoto, Texas, 75115
Mink Sandhu, LMSW, 945-297-0835, msandhu@adamsclinical.com
Rajinder Shiwach, MD
- Recruiting
Adams Clinical, Harlem
New York, New York, 10029
Tessa Candiotti, LCSW, 347-238-3704, tcandiotti@adamsclinical.com
Wesley Gregory, PHD
- Recruiting
Adams Clinical, Philadelphia
Philadelphia, Pennsylvania, 19104
Cassie Blanchard, PHD, 617-209-3304, cblanchard@adamsclinical.com
Cassie Blanchard, PHD
- Recruiting
Adams Clinical, Bronx
The Bronx, New York, 10461
Billye Weiner, LMSW, 347-218-9604, bweiner@adamsclinical.com
Shama Farooq, MD
- Recruiting
Adams Clinical, Watertown
Watertown, Massachusetts, 02472
Miriam Evans, PhD, 617-744-8542, mevans@adamsclinical.com
Miriam Evans, PhD
About this study
TRIAGE-Psych is a survey study designed to assess potential participants' eligibility to screen for industry-sponsored psychiatry clinical trials.
- Being tested
- Survey
- Medical subject headings
- Depressive Disorder, Major, Borderline Personality Disorder, Generalized Anxiety Disorder
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
SurveyOther
Participants will be surveyed on demographics, medical history, and current psychiatric symptoms. Vital signs, urine drug screens, and urine pregnancy tests may be collected.
What is being measured
The primary outcome is the main question the study is designed to answer.
The proportion of participants who are eligible for industry-sponsored clinical trials, as defined as those who go on to screen for a study
Measured: Up to 52 weeks
Secondary outcomes (2)
The proportion of participants who enroll in industry-sponsored clinical trials
Measured: Up to 52 weeks
The prevalence of disqualifying comorbid conditions that prevent screening or enrollment in industry-sponsored clinical trials
Measured: Up to 52 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Apr 2023
- Study start21 Dec 2021
- Primary completion31 Dec 2027 (estimated)
- Study completion31 Dec 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Major Depressive DisorderStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Prospective
- Enrolment
- 20,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Adams Clinical
- Sponsor type
- Research network
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05800925
- Sponsor's protocol ID
- TRIAGE-Psych-101
- Acronym
- TRIAGE-Psych
- Status last verified
- May 2026
- First submitted
- 24 Mar 2023
- Last updated
- 20 May 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 20 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Triage Survey for Psychiatry Research Eligibility
- ClinicalTrials.gov ID
- NCT05800925
- Acronym / sponsor ID
- TRIAGE-Psych / TRIAGE-Psych-101
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 20,000 participants (estimated)
- Lead sponsor
- Adams ClinicalResearch network
- Study start
- 21 Dec 2021 (actual)
- Primary completion
- 31 Dec 2027 (estimated)
- Study completion
- 31 Dec 2027 (estimated)
- First posted
- 6 Apr 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
TRIAGE-Psych is a survey study designed to assess potential participants' eligibility to screen for industry-sponsored psychiatry clinical trials.
Study design
- Observational model
- Case only
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Participants of any sex, age 18+, who have expressed interest in participating in an industry-sponsored clinical trial of an investigational product for indications in psychiatry will be screened for clinical appropriateness for a study trial.
Key inclusion criteria (2 listed)
- Participant or Legally Authorized Representative has signed an ICF prior to study-specific procedures being performed.
- Participant is at least 18 years old.
Key exclusion criteria (6 listed)
- Participant is pregnant, breast-feeding, or planning to become pregnant.
- History of a clinically significant illness which in the investigator's opinion may impact participant safety or the ability to analyze study results.
- Participant represents an acute suicidal risk, as defined as a "yes" response to ideation on C-SSRS questions 4 or 5, or answer "yes" to behavior questions within 90 days of screening.
- Moderate or severe substance use disorder within 90 days prior to screen, according to DSM-5 criteria that in the investigator's opinion could pose undue risk to the participant.
- Any condition that in the investigator's opinion makes a participant unsuitable for the study.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| SurveyParticipants will be surveyed on demographics, medical history, and current psychiatric symptoms. Vital signs, urine drug screens, and urine pregnancy tests may be collected. | Other | – |
Primary outcome
The proportion of participants who are eligible for industry-sponsored clinical trials, as defined as those who go on to screen for a study
Time frame: Up to 52 weeks
2 secondary outcomes
The proportion of participants who enroll in industry-sponsored clinical trials
Time frame: Up to 52 weeks
The prevalence of disqualifying comorbid conditions that prevent screening or enrollment in industry-sponsored clinical trials
Time frame: Up to 52 weeks
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 May 2026.
Related trials for Major Depressive Disorder
Not yet recruiting
Preventive and Personalized Digital Emotion Regulation Skills Intervention to Reduce Depression and Anxiety in Youths With Adverse Childhood Experiences
Adverse Childhood Experience, Depression / Major Depressive Disorder
RecruitingPhase 4
Biomarker-Guided Antidepressant Selection
Depression - Major Depressive Disorder, Treatment-resistant Depression (TRD)
Recruiting
Targeting Network Dysfunction in Apathy of Late-life Depression Using Digital Therapeutics
Major Depressive Disorder, Apathy
RecruitingObservational study
Student Precarity and Psychiatry
Depressive Disorder, Major, Generalized Anxiety Disorder
Not yet recruiting
Acute Intermittent Hypoxia Therapy for Depression
Major Depressive Disorder (MDD)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
6 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Major Depressive Disorder and Borderline Personality Disorder, run by Adams Clinical at 6 sites in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 20 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 6 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Miriam Evans, PhD (617-744-8542, mevans@adamsclinical.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
The proportion of participants who are eligible for industry-sponsored clinical trials, as defined as those who go on to screen for a study (time frame: Up to 52 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 May 2026.